Stoke Therapeutics, Inc. (STOK) has a market capitalization of $2.12B and trades at $35.86. The 52-week range is 5.35-40.22.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -298.8, Earnings Per Share (EPS) of $-0.12, annual revenue of $184.42M.
The stock has a beta of 1.22, operates in the Healthcare sector.
